Reduction of the in vivo burst release of insulin-loaded microparticles

Journal of Drug Delivery Science and Technology

Volumn 30, Issue , 2015, Pages 486-493

  Sheikh Hasan, A ^a   Sapin, A ^a   Damge C ^a   Leroy, P ^a   Socha, M ^a   Maincent, P ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Burst release; Composite microparticles; Diabetic rats; Insulin; Poly (lactic co glycolic) acid; Poly ( caprolactone); Subcutaneous delivery

Indexed keywords

INSULIN; NEUTRAL INSULIN; POLYCAPROLACTONE; POLYVINYL ALCOHOL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TREATMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

EID: 84949565695     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.06.020     Document Type: Article

References (36)

1. Y. Shi, and L.C. Li Current advances in sustained-release systems for parenteral drug delivery Expert Opin. Drug Deliv. 2 2005 1039 1058
2. H. Reithmeier, J. Herrmann, and A. Gopferich Lipid microparticles as a parenteral controlled release device for peptides J. Control. Release 73 2001 339 350
3. X. Huang, and C.S. Brazel On the importance and mechanisms of burst release in matrix-controlled drug delivery systems J. Control. Release 73 2001 121 136
4. Y. Yeo, and K. Park Control of encapsulation efficiency and initial burst in polymeric microparticle systems Arch. Pharm. Res. 27 2004 1 12
5. R.C. Mehta, B.C. Thanoo, and P.P. DeLuca Peptide containing microspheres from low molecular weight and hydrophilic poly(DL-lactide-co-glycolide) J. Control. Release 41 1996 249 257
6. Y.Y. Yang, T.S. Chung, and N. Ping Ng Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method Biomaterials 22 2001 231 241
7. S. Nicoli, P. Santi, P. Couvreur, G. Couarraze, P. Colombo, and E. Fattal Design of triptorelin loaded nanospheres for transdermal iontophoretic administration Int. J. Pharm. 214 2001 31 35
8. J. Wang, K.M. Chua, and C.H. Wang Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres J. Colloid Interf. Sci. 271 2004 92 101
9. A. Aubert-Pouëssel, M.C. Venier-Julienne, A. Clavreul, M. Sergent, C. Jollivet, C.N. Montero-Menei, E. Garcion, D.C. Bibby, P. Menei, and J.P. Benoit In vitro study of GDNF release from biodegradable PLGA microspheres J. Control. Release 95 2004 463 475
10. A. Sánchez, M. Tobío, L. González, A. Fabra, and M.J. Alonso Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha Eur. J. Pharm. Sci. 18 2003 221 229
11. A. Sheikh Hasan, M. Socha, A. Lamprecht, F. Ghazouani, A. Sapin, M. Hoffman, P. Maincent, and N. Ubrich Effect of the microencapsulation of nanoparticles on the reduction of burst release Int. J. Pharm. 344 2007 53 61
12. A. Sheikh Hasan, A. Sapin, A. Lamprecht, E. Emond, F. El Ghazouani, and P. Maincent Composite microparticles with in vivo reduction of the burst release effect Eur. J. Pharm. Biopharm. 73 2009 337 344
13. M. Takenaga, Y. Yamaguchi, A. Kitagawa, Y. Ogawa, S. Kawai, Y. Mizushima, and R. Igarashi Optimum formulation for sustained-release insulin Int. J. Pharm. 271 2004 85 94
14. Y. Yamaguchi, M. Takenaga, A. Kitagawa, Y. Ogawa, Y. Mizushima, and R. Igarashi Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives J. Control. Release 81 2002 235 249
15. T. Haak New developments in the treatment of type 1 diabetes mellitus Exp. Clin. Endocrinol. Diabetes 107 1999 S108 S113
16. K.D. Hinds, K.M. Campbell, K.M. Holland, D.H. Lewis, C.A. Piche, and P.G. Schmidt PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis J. Control. Release 104 2005 447 460
17. M. Takenaga, Y. Yamaguchi, A. Kitagawa, Y. Ogawa, Y. Mizushima, and R. Igarashi A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release J. Control. Release 79 2002 81 91
18. S. Furtado, D. Abramson, L. Simhkay, D. Wobbekind, and E. Mathiowitz Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats Eur. J. Pharm. Biopharm. 63 2006 229 236
19. S. Choi, and S.W. Kim Controlled release of insulin from injectable biodegradable triblock copolymer depot in ZDF rats Pharm. Res. 20 2003 2008 2010
20. V. Hoffart, N. Ubrich, C. Simonin, V. Babak, C. Vigneron, M. Hoffman, T. Lecompte, and P. Maincent Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics Drug Dev. Ind. Pharm. 28 2002 1091 1099
21. T. Freytag, A. Dashevsky, L. Tillman, G.E. Hardee, and R. Bodmeier Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres J. Control. Release 69 2000 197 207
22. P. Moslemi, A.R. Najafabadi, and H. Tajerzadeh A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high performance liquid chromatography J. Pharm. Biomed. Anal. 33 2003 45 51
23. C. Damgé, C. Michel, M. Aprahamian, and P. Couvreur New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier Diabetes 37 1988 246 251
24. J. Gerich Novel insulins: expanding options in diabetes management Am. J. Med. 113 2002 308 316
25. J. Mayfield, and R. White Insulin therapy for type 2 diabetes: rescue, augmentation and replacement of beta-cell function Am. Fam. Physician 70 2004 489 500
26. C.P. Reis, A.J. Ribeiro, S. Houng, F. Veiga, and R.J. Neufeld Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity Eur. J. Pharm. Sci. 30 2007 392 397
27. Y.F. Fan, Y.N. Wang, Y.G. Fan, and J.B. Ma Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption Int. J. Pharm. 324 2006 158 167
28. A. Grenha, B. Seijo, and C. Remuñán-López Microencapsulated chitosan nanoparticles for lung protein delivery Eur. J. Pharm. Sci. 25 2005 427 437
29. R.L. Graves, M.C. Makoid, and S. Jonnalagadda The effect of coencapsulation of bovine insulin with cyclodextrins in ethylcellulose microcapsules J. Microencapsul. 22 2005 661 670
30. G. De Rosa, D. Larobina, M. Immacolata La Rotonda, P. Musto, F. Quaglia, and F. Ungaro How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system J. Control. Release 102 2005 71 83
31. G. Jiang, W. Qiu, and P.P. DeLuca Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres Pharm. Res. 20 2003 452 459
32. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats Int. J. Pharm. 184 1999 189 198
33. A.L. Weiner, S.S. Carpenter-Green, E.C. Soehngen, R.P. Lenk, and M.C. Popescu Liposome-collagen gel matrix: a novel sustained drug delivery system J. Pharm. Sci. 74 1985 922 925
34. www.theriaque.org, Update 08.04.08, view 8 April.
35. D. Attivi, P. Wehrlé, N. Ubrich, C. Damgé, M. Hoffman, and P. Maincent Formulation of insulin-loaded polymeric nanoparticles using response surface methodology Drug Dev. Ind. Pharm. 31 2005 179 189
36. D.J. Chetty, and Y.W. Chen Novel methods of insulin delivery: an update Crit. Rev. Ther. Drug Carr. Syst. 15 1998 629 670